@article{f7f1fe9fe9654422a049b7689e23b46c,
title = "Sorafenib and novel multikinase inhibitors in AML",
author = "Naval Daver and Marina Konopleva",
note = "Funding Information: ND reports grants from Novartis; grants and personal fees from Incyte; grants and personal fees from Sunesis; grants from Bristol-Myers Squibb; and grants and personal fees from Karyopharm, outside the submitted work. MK reports grants from AbbVie, Novartis, and Lilly Oncology, outside the submitted work.",
year = "2015",
doi = "10.1016/S1470-2045(15)00454-4",
language = "English (US)",
volume = "16",
pages = "1582--1583",
journal = "The Lancet Oncology",
issn = "1470-2045",
publisher = "Elsevier Ltd",
number = "16",
}